The Korean Journal of Blood Transfusion : eISSN 2383-6881 / pISSN 1226-9336

Table. 3.

Table. 3.

Characteristics of the neonates with presence of maternal unexpected antibody

Case numberMotherNeonate


Antibody specificityABO blood typeGestational age at birthABO blood typeDATPhoto-therapyTotal bilirubin (mg/dL)Hemo-globin (g/dL)Age (days) at test
1Anti-DA (–)38+5 wksA (+)NegativeNo6.6816.32
2Anti-DAB (–)40+0 wksA (+)NANo5.5915.23
3Anti-DO (–)35+5 wksB (+)NAYesNA16.21
4Anti-DO (–)38+4 wksO (+)NegativeYes7.4317.14
5Anti-DA (–)28+1 wksO (+)NAYes7.416.16
6Anti-DA (–)38+6 wksA (+)NANoNANANA
7Anti-DA (–)37+5 wksO (+)NANoNANANA
8Anti-C & eA (+)36+0 wksA (+)NAYes7.0416.74
9Anti-EO (+)17+5 wks******
10Anti-EA (+)37+1 wksB (+)NANoNANANA
11Anti-E & cA (+)41+1 wksA (+)NANo2.8314.91
12Anti-E & cO (+)7+1 wks******
13Anti-E & FybB (+)37+5 wks******
14Anti-E & DibB (+)36+2 wksO (+)PositiveNo6.2715.715
15Anti-JkaA (+)38+1 wksAB (+)NAYes5.214.13
16Anti-LeaA (+)36+4 wksA (+)NAYesNANANA
17Anti-LeaO (+)37+4 wksB (+)NANo7.2116.58
18Anti-LeaAB (+)33+4 wksAB (+)NAYes8.9413.96
19Anti-LeaA (+)36+4 wksA (+)NAYesNANANA
20Anti-LeaA (+)37+4 wksO (+)NANo2.5217.81
21Anti-MO (+)37+3 wksO (+)NANoNANANA
22Unidentified Ab.O (+)37+0 wksA (+)NAYes7.3615.13
23Unidentified Ab.O (+)37+6 wksO (+)NANo8.716.43
24Unidentified Ab.A (+)34+0 wksB (+)NAYes14.5214.74
25Unidentified Ab.B (+)34+5 wksA (+)NAYesNANANA
26Unidentified Ab.B (+)37+1 wksA (+)NANo7.8813.316
27Unidentified Ab.B (+)7+6 wks******
28Unidentified Ab.AB (+)37+0 wksAB (+)NANoNANANA
29Unidentified Ab.AB (+)22+4 wks******
30Positive, NTA (+)38+1 wksA (+)NAYes8.5515.65
31Positive, NTB (+)35+0 wksB (+)NAYes10.9517.46
32Positive, NTB (+)38+3 wksO (+)NANoNANANA
33Positive, NTO (+)37+5 wksA (+)NANoNANANA
34Positive, NTO (+)37+3 wksB (+)NANoNANANA
35Positive, NTB (+)5+3 wks******
36Positive, NTB (+)38+0 wksA (+)NANoNANANA
37Positive, NTO (+)38+0 wksB (+)NANoNANANA

*The cases of abortion or intra-uterine fetal death.

Abbreviations: Ab., antibody; DAT, direct antiglobulin test; NT, not tested of identification; NA, no data available.

Korean J Blood Transfus 2019;30:23-32 https://doi.org/10.17945/kjbt.2019.30.1.23
© 2019 Korean J Blood Transfus